Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kui Liu, Quan-Zhen Li, Angelica M. Delgado-Vega, Anna-Karin Abelson, Elena Sánchez, Jennifer A. Kelly, Li Li, Yang Liu, Jinchun Zhou, Mei Yan, Qiu Ye, Shenxi Liu, Chun Xie, Xin J. Zhou, Sharon A. Chung, Bernardo Pons-Estel, Torsten Witte, Enrique de Ramón, Sang-Cheol Bae, Nadia Barizzone, Gian Domenico Sebastiani, Joan T. Merrill, Peter K. Gregersen, Gary G. Gilkeson, Robert P. Kimberly, Timothy J. Vyse, Il Kim, Sandra D’Alfonso, Javier Martin, John B. Harley, Lindsey A. Criswell, The Profile Study Group, The Italian Collaborative Group, The German Collaborative Group, The Spanish Collaborative Group, The Argentinian Collaborative Group, The SLEGEN Consortium, Edward K. Wakeland, Marta E. Alarcón-Riquelme, Chandra Mohan
Published in Volume 119, Issue 4
J Clin Invest. 2009; 119(4):911–923 doi:10.1172/JCI36728
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
The differential renal expression of Klk in the AIGN-sensitive versus control strains was confirmed at the protein level.

BALB/c, DBA1, and 129/SvJ mice were subjected to AIGN. (A) Fourteen days after anti-GBM challenge, kallikrein protein expression was assayed in the renal cortex by Western blotting, using a rabbit anti–mouse Klk1 Ab. The bar chart below (n = 3 mice per group) shows Klk expression normalized to GAPDH (AU). *P < 0.001, compared with all other study groups. (B) Twenty-four-hour urine samples collected from these mice on days 0, 10, and 14 after anti-GBM insult were also assayed for kallikrein enzymatic activity, using the synthetic chromogenic substrate HD-Val-Leu-Arg-pNA (S-2266), as detailed in Methods. Similar differences in renal and urinary kallikrein levels were noted between B6 and B6.Sle3z mice (data not shown). Error bars in A denote SD. In B, each dot represents data from a single mouse, and the horizontal bars denote arithmetic group means.